gvtcx

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£29,200,000
Statuscomplete
Category (CPV) 33651660
Deadline2 Jun 2021
Procedureopen
OCIDocds-h6vhtk-02aa9d

Awards (3)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £29,200,000.

SupplierValueDateStatus
Aventis Pharma ltd t/a Sanofi shared · · active
Seqirus UK Limited shared · · active
not named shared · · unsuccessful

description

NHS Framework Agreement for the supply of Adult Influenza Vaccines – Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
27 Apr 2021 Contract notice (F02) Earlier regulations 009004-2021
8 Sept 2021 Contract award notice (F03) Earlier regulations 022304-2021

more from The NHS Commissioning Board (operating under the name of NHS England)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.